Implementation of artificial intelligence (AI) for lung cancer clinical trial matching in a tertiary cancer center von Leventakos, K., Helgeson, J., Mansfield, A.S., Deering, E., Schwecke, A., Adjei, A., Molina, J., Hocum, C., Halfdanarson, T., Marks, R., Parikh, K., Pomerleau, K., Coverdill, S., Rammage, M., Haddad, T.

Volltext

Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy von Duma, N., Azzouqa, A.-G., Yadav, S., Hoversten, K., Reed, C., Sitek, A.N., Lou, Y., Molina, J., Halfdanarson, T., Leventakos, K., Joseph, R.W., Manochakian, R., Dronca, R.

Volltext

88P Use of brain imaging in the management of patients with lymph node negative multifocal lung cancer von Leventakos, K., Mansfield, A.S., Blackmon, S., Cassivi, S., Shen, R., Nichols, F.C., Molina, J.R., Allen, M.S., Aubry, M.C., Wigle, D.

Volltext

Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hosp... von Mastorakis, E., Meristoudis, C., Margari, N., Pouliakis, A., Leventakos, K., Chroniaris, N., Panayiotides, I., Karakitsos, P.

Volltext

38P Brain metastases in non-small cell lung cancer in era of molecularly driven therapy von Rakshit, S., Bansal, R., Desai, A., Leventakos, K.

Volltext

901P Cisplatin vs carboplatin in extrapulmonary neuroendocrine carcinoma von McLaughlin, N., McGarrah, P., Eiring, R., Leventakos, K., Sonbol, M.B., Starr, J.S., Hobday, T.J., Halfdanarson, T.R.

Volltext

MA10.07 Understanding Symptom Burden in Young Adults with Lung Cancer Based on an Analysis from the E2C2 Pragmatic Clinical Trial von Smith, K., Leventakos, K., Grzegorczyk, V., Griffin, J., Liu, B., Mina, S., Pachman, D., Ruddy, K., Cheville, A.

Volltext

PP01.55 Real-World Treatment Sequencing and Impact on Outcomes in ALK-Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) von Wan, Y., Elliott, J., Young, M., Yin, Y., Arnaoutakis, K., Leventakos, K., Lin, H.M., Dimou, A.

Volltext

Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them? von Leventakos, Konstantinos, Lewis, Russell E., Kontoyiannis, Dimitrios P.

Volltext

EP14.05-001 Chemoimmunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer and ECOG Performance Status of 2 or 3 von Agarwal, M., Liu, A., Langlais, B., Leventakos, K., Yu, N.Y., Almquist, D., Manochakian, R., Ernani, V.

Volltext

EP.14B.06 A Retrospective Multicenter Study Evaluating Experience of Perioperative Treatment for Thymic Squamous Cell Carcinoma von Singh, A., Sridhar, A., Shakya, P., Moffet, J.N., Schwecke, A., Luce, A., Shanshal, M., Dimou, A., Leventakos, K., Mansfield, A., Molina, J., Parikh, K.

Volltext

50P Patient-reported outcomes in non-small cell lung cancer patients receiving immunotherapy monotherapy: Analysis from enhanced, EHR-facilitated cancer symptom control (E2C2) prag... von Liu, B., Lam, V., Pachman, D., Ruddy, K., Burke, O., Lingamaneni, P., Yu, Y., Jiang, G., Cheville, A., Leventakos, K.

Volltext

503LBA LBA Orals: Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTA... von Rodon, J., Jänne, P.A., Leventakos, K., George, B., Henry, J.T., Johnson, M.L., Papadopoulos, K.P., Batista, A.I., Spira, C.P., Zhao, Y., Zuniga, R., Shoukier, M., Ernani, V., Haddox, C.L., Wozniak, A., Mariotti, V., Mazzei-Abba, A., Shazer, R., Yang, W., Arbour, K.C.

Volltext

EP11.03-26 Real-World Outcomes with Immunotherapy Compared to Chemoimmunotherapy in Metastatic NSCLC with High PDL1 Expression von Parikh, K., Leventakos, K., Mansfield, A.S., Dimou, A., Molina, J.R., Ambrose, J., Bai, C., Hansen, E., Barcellos, A., Zettler, C., Belli, A., Fernandes, L., Wang, C.-K.

Volltext

EP14.04-01 BRCA-Associated Protein-1 (BAP1) Loss and Real-World Outcomes of Immune Checkpoint Inhibitor Therapy in Pleural Mesothelioma von Smith, C.J., Desai, A., Hazim, A., Dimou, A., Leventakos, K., Molina, J., Parikh, K., Kommalapati, A., Hocum, C., Moffett, J.N., Schwecke, A., Mansfield, A.S.

Volltext

1133P Additional practice-informing adverse event patterns and management in the KRYSTAL-1 phase II study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC von Zhang, J., Leventakos, K., Leal, T.A., Pennell, N., Barve, M., Paulson, A.S., Bazhenova, L., Johnson, M.L., Chao, R.C., Velastegui, K., Qian, C., Bleker, W., Spira, A.

Volltext

EP07.01-08 Development of a Shared Decision-Making Tool for Adjuvant Treatment for Patients with Resected Non-Small Cell Lung Cancer von Soto Jacome, C., Hargraves, I., Ashara, Y., Algarin Perneth, S., Sivly, A., Gravholt, D., Sagen, C., Brito, J., Montori, V., Leventakos, K.

Volltext

P2.12-09 Targeted and Immunotherapy Associated Cardiotoxicity in Stage IV Lung Cancer Patients with and without Cardiac Comorbidities von Peng, Y., Li, D., Wampfler, J.A., Luo, Y., Kumar, A.V., Gu, Z., Kosuru, N., Yu, N.Y., Wang, Z., Leventakos, K., Ernani, V., Yang, P.

Volltext

EP.07C.16 Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy von Hazim, A., Xiao, A., Singh, A., Chung, K., Reck dos Santos, P.A., D'Cunha, J., Shanshal, M., Dimou, A., Parikh, K., Lou, Y., Manochakian, R., Leventakos, K., Molina, J., Mansfield, A., Ernani, V.

Volltext

P2.14A.14 A Real-World Multicenter Retrospective Study of Treatment Outcomes with Ipilimumab and Nivolumab in Mesothelioma von Sridhar, A., Schwecke, A., Durer, S., Hsu, M.L., Singh, A., Mansfield, A.S., Lou, Y., Molina, J.R., Leventakos, K., Dimou, A., Manochakian, R., Shanshal, M., Ernani, V., Moffett, J.N., Luce, A., Parikh, K.

Volltext